Skip to main contentAll experts

Danielle Cerbon

CLIN AST PROF

MD-RADIATION ONCOLOGY

  • CLIN AST PROF
    MD-RADIATION ONCOLOGY

GRANTS

  • GRANT
    A Phase II Study of Tailored Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer (RAINBO BLUE & TAPER)
    National Institute of Health Nci13 May 2026 - 12 May 2031
    Active